ZOLL Sponsors Second Annual “Chilling At The Beach” Conference On Temperature Management In Miami
ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical
devices and related software solutions, announced today that it recently
provided an educational grant to sponsor the second annual “Chilling at
ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that it recently provided an educational grant to sponsor the second annual “Chilling at the Beach─Therapeutic Hypothermia and Temperature Management: Current and Future Directions” conference hosted by the University of Miami Miller School of Medicine. During the two-day meeting, key thought leaders from around the world representing multiple specialities convened to discuss when therapeutic hypothermia is most appropriate to use and under what conditions temperature management is helpful for various indications. The lectures and roundtable discussions attracted an international audience from pediatrics, nursing, cardiology, neurology, intensivists, surgeons, and emergency care physicians representing specialties such as acute myocardial infarction, sudden cardiac arrest, burn, surgery, neuro fever, and stroke. They came to learn about the latest temperature management science ranging from anti-shivering protocols to managing complications onto temperature management in emerging areas such as pediatric cardiac surgery and hypothermia for organ transplantation. According to Course Director W. Dalton Dietrich, III, PhD, Scientific Director, the Miami Project to Cure Paralysis and Professor of Neurological Surgery, University of Miami Miller School of Medicine, the four conference tracks offered discussions on ICU and intra-operative temperature management, temperature management strategies, the future of temperature management, and bench-to-bedside cooling strategies. “The 2012 Chilling at the Beach Miami Conference attracted over 130 attendees who discussed and debated a wide range of temperature related topics important to the critical care of patients with acute and chronic injuries. The significance of this year’s conference is that clinicians, critical care nurses, and scientists from many diverse specialties gathered at one conference to learn and discuss the benefits of temperature management and therapeutic hypothermia for a widening range of indications,” said Dr. Dietrich. “The fields of post-cardiac arrest, head trauma, acute spinal injury, stroke, seizures, and organ transplantation were well-represented at the conference.”
Zoll Medical Corporation (Nasdaq:ZOLL) hit a new 52-week high Monday as it is currently trading at $93.29, above its previous 52-week high of $93.02 with 1.2 million shares traded as of 3:55 p.m. ET. Average volume has been 336,400 shares over the past 30 days.
Shares of Zoll Medical Corporation (Nasdaq:ZOLL) have taken a tremendous swing upward. The stock is trading at $92.95 as of 9:30 a.m. ET, 23.8% above Friday's closing price of $75.10. Volume is at 972,021, 2.9 times the daily average of 336,400.